IN BRIEF: Kingsley Capital reduces stake in Oxford Cannabinoid lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Oxford Cannabinoid Technologies Holdings PLC - Oxford-based pharmaceutical company developing prescription cannabinoid medicine - Kingsley Capital Partners LLP sells 54.9 million shares in the.
Explore Oxford Cannabinoid Technologies Holdings's Company Regulatory News (RNS) and non regulatory news updates for the latest insights on their financial performance, stock market status, and corporate governance. Stay informed about Oxford Cannabinoid Technologies Holdings's share price and industry developments. If you're an investor tracking the latest RNS announcements for Oxford Cannabinoid Technologies Holdings or just want to find out what has happened to Oxford Cannabinoid Technologies Holdings share price as it happens.
Shares in Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF) rose 6% following the successful completion of the phase I study for its lead.
Oxford Cannabinoid Technologies Holdings PLC on Tuesday said it has successfully completed the dosing of all the cohorts of its Phase 1 study for its lead pharmaceutical asset, OCT461201.
The.